Drug Development

Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer.

Charm Sciences is a world leading provider of food safety diagnostic tests custom manufactured to meet an ever-changing global regulatory environment. Over the years, Charm has extended its diagnostic portfolio to include test kits and integrated programs for antibiotics, mycotoxins, pesticides, alkaline phosphatase, pathogens, end-product microbial assessment, allergen control, and ATP.

Bruker Daltonics is a pioneer and leader in providing enabling life science tools based on mass spectrometry for the post-genomic revolution

Biogen Idec Inc. is focused on developing treatments in the areas of oncology, immunology, and neurology. Its product roster includes best-selling Avonex, the most popular drug for the treatment of relapsing multiple sclerosis.

Applied Biosystems Group, a unit of Applied Biosystems Inc. makes the big machines for life scientists to peer into the details of DNA and proteins. Its product line includes systems that detect the polymerase chain reactions used to identify DNA sequences. The unit also provides gene expression assays for various species, specialized enzymes called reagents, and disposable plastic devices to hold DNA samples.

pSivida is a leading provider of miniaturized, sustained-release drug delivery products and is continuing the evolution of these systems.

Alkermes focuses on therapies for widespread, chronic diseases, such as central nervous system disorders, addiction, diabetes and autoimmune disorders, where we feel we have the opportunity to make the greatest impact.

Merrimack Pharmaceuticals are dedicated to the discovery and development of innovative therapies for the treatment of autoimmune disease and cancer. Merrimack is advancing a robust pipeline of clinical and early-stage biologics that represent the next generation of patient-directed, targeted therapies.

JEOL develops instruments used to advance scientific research and technology. JEOL has expertise in the field of electron microscopy, mass spectrometry and NMR spectrometry, and e-beam lithography leadership.

Palmetto Pharmaceuticals is a drug development company recently formed from the leveraged purchase of substantially all of the assets of eNOS Pharmaceuticals of Cambridge,MA and certain intellectual property assets of Angiogenix,Inc of San Francisco,CA. These two companies had done extensive pre-clinical and clinical work on the development of combination therapies that addressed the improved endothelial function and enhanced blood flow resulting when the amino acid L-arginine was administered with statins.